Vir Biotechnology Inc. (VIR)
NASDAQ: VIR
· Real-Time Price · USD
4.51
0.07 (1.58%)
At close: Aug 15, 2025, 3:59 PM
4.49
-0.43%
After-hours: Aug 15, 2025, 07:24 PM EDT
Vir Biotechnology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 16.67M | 18.53M | 73.11M | 78.62M | 72.14M | 56.34M | 46.68M | 51.68M | 427.21M | 397.25M | 1.58B | 2.37B | 2.1B | 2.32B | 1.09B | 277.61M | 175.08M | 67.36M |
Cost of Revenue | 745K | 5.05M | 9.62M | 14.21M | 14.2M | 9.91M | 7.24M | 7.96M | 30.18M | 58.08M | 146.32M | 197.2M | 182.78M | 156.01M | 200.73M | 144.15M | 207M | 285.51M |
Gross Profit | 15.92M | 13.48M | 63.49M | 64.4M | 57.94M | 46.43M | 39.44M | 43.72M | 397.03M | 339.17M | 1.43B | 2.17B | 1.92B | 2.16B | 886.33M | 133.45M | -31.92M | -218.14M |
Operating Income | -593.71M | -604.65M | -517.59M | -517.55M | -485.69M | -571.51M | -662.4M | -695.79M | -314.1M | -324.13M | 833.07M | 1.56B | 1.31B | 1.59B | 420.75M | -259.4M | -293.63M | -383.7M |
Interest Income | 54.75M | 62.81M | 71.81M | 78.39M | 82.8M | 86.97M | 86.99M | 82.43M | 69.83M | 49.01M | 28.09M | 12.09M | 2.77M | 663K | 439K | 560K | 961K | 1.69M |
Pretax Income | -549.95M | -579.05M | -523.11M | -539.19M | -492.27M | -550.01M | -628.19M | -659.08M | -274.72M | -310.81M | 754.28M | 1.45B | 1.34B | 1.64B | 549.8M | -101.77M | -297.12M | -390.1M |
Net Income | -550.23M | -577.65M | -521.96M | -533.34M | -483.04M | -539.44M | -615.12M | -600.75M | -262.02M | -143.74M | 515.84M | 1.14B | 1.08B | 1.22B | 528.58M | -102.32M | -297.36M | -390.34M |
Selling & General & Admin | 98.67M | 106.65M | 118.98M | 131.37M | 146.71M | 163.54M | 174.05M | 173.7M | 175.8M | 170.28M | 161.76M | 178.8M | 186.12M | 173.31M | 160.79M | 128.06M | 96.42M | 84.03M |
Research & Development | 517.41M | 517.77M | 467.13M | 450.58M | 403.66M | 477.66M | 567.29M | 632.93M | 598.84M | 542.06M | 474.65M | 447.82M | 432.32M | 403.36M | 448.01M | 406.76M | 378.77M | 372.3M |
Other Expenses | 4.33M | 3.8M | 4.76M | 9.8M | 60K | 228K | -15.73M | -43.35M | -47.36M | -46.3M | -32.58M | -4.96M | -1.77M | -1.71M | -9.44M | -6.99M | -4.44M | -8.09M |
Operating Expenses | 622.51M | 630.85M | 593.79M | 594.67M | 543.63M | 617.95M | 701.84M | 739.51M | 711.13M | 663.3M | 601.09M | 615.92M | 609.96M | 567.17M | 600.45M | 528.03M | 467.57M | 451.07M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30.04M | 30.04M | 30.04M | 30.04M | n/a | n/a | n/a |
Cost & Expenses | 621.16M | 633.8M | 601.32M | 606.79M | 557.83M | 627.86M | 709.08M | 747.47M | 741.31M | 721.38M | 747.4M | 813.12M | 792.75M | 723.18M | 666.31M | 537.01M | 468.71M | 451.07M |
Income Tax Expense | -63K | -1.41M | -1.15M | -5.84M | -9.23M | -10.57M | -13.08M | -58.33M | -12.7M | -167.07M | 238.44M | 309.11M | 267.03M | 424.31M | 21.22M | 553K | 241K | 234K |
Shares Outstanding (Basic) | 138.45M | 137.47M | 136.81M | 136.65M | 136.23M | 135.28M | 134.61M | 134.29M | 134.06M | 133.55M | 133.15M | 132.73M | 132.45M | 132.08M | 130.97M | 130.67M | 130.12M | 127.74M |
Shares Outstanding (Diluted) | 138.45M | 137.47M | 136.81M | 136.65M | 136.23M | 135.28M | 134.61M | 134.29M | 134.06M | 133.55M | 133.15M | 134.96M | 132.45M | 134.54M | 133.88M | 133.85M | 133.79M | 127.74M |
EPS (Basic) | -4 | -4.22 | -3.82 | -3.92 | -3.58 | -4.01 | -4.59 | -4.49 | -1.95 | -1.08 | 3.91 | 8.68 | 8.21 | 9.27 | 4.02 | -0.82 | -2.34 | -3.09 |
EPS (Diluted) | -4 | -4.22 | -3.82 | -3.92 | -3.58 | -4.01 | -4.59 | -4.49 | -1.97 | -1.1 | 3.81 | 8.49 | 8.01 | 9.05 | 3.88 | -0.87 | -2.36 | -3.09 |
EBITDA | -584.86M | -594.54M | -533.41M | -553.89M | -520.34M | -597.32M | -659.49M | -673.5M | -296.39M | -314.94M | 836.62M | 1.53B | 1.29B | 1.57B | 400.87M | -254.48M | -288.76M | -377.47M |
EBIT | -597.83M | -611.6M | -537.04M | -554.96M | -523.1M | -600.57M | -678.94M | -690.42M | -285.96M | -301.36M | 763.91M | 1.46B | 1.19B | 1.48B | 395.74M | -258.56M | -292.79M | -383.7M |
Depreciation & Amortization | 8.65M | 12.91M | 14.56M | 16.15M | 19.66M | 22.38M | 25.67M | 25.38M | 22.85M | 19.64M | 15.49M | 14.53M | 13.64M | 12.79M | 12.01M | 10.13M | 8.58M | 7.02M |